Order Online! Now! Get your $50 coupon for online order.
Order Online! Now! Get your $50 coupon for online order.
Get your basement membrane extract free sample to test now!
Get your basement membrane extract free sample to test now!
Time Limited Offer: Welcome Gift for New Customers !
Shipping Price Reduction for EU Regions
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
NP1-H82E9 | Human | Biotinylated Human NPR1 / NPRA Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
|
NP1-H5259 | Human | Human NPR1 / NPRA Protein, Fc Tag (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
The purity of Human NPR1, Fc Tag (Cat. No. NP1-H5259) is more than 90% and the molecular weight of this protein is around 165-190 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Carperitide | SUN-4936; SUN-4936h; SUN-4936r; SUN-Y4936r; alpha-hANP; ANF (99-126); ANP (99-126); CDD (99-126) | Approved | Daiichi Sankyo Co Ltd | HANP | Japan | Heart Failure | Daiichi Sankyo Co Ltd | 1995-01-20 | Heart Failure; Respiratory Distress Syndrome, Adult; Cardiomyopathies | Details |
Recombinant human brain natriuretic peptide (Tibet Rhodiola) | Approved | Tibet Rhodiola Pharmaceutical Holding Company | 新活素 | Mainland China | Heart Failure | Chengdu Rhodiola Bio-Pharmaceutical Co Ltd | 2005-04-11 | Heart Failure; Acutely decompensated congestive heart failure | Details | |
Sodium Nitroprusside | SNP | Approved | F. Hoffmann-La Roche Ltd | Nipride, Nitriate, Nitropress | Mainland China | Heart Failure; Hypertension | China Resources Double-Crane Pharmaceutical Co Ltd | 1974-05-10 | Hypotension; Schizophrenia; Heart Failure; Hypertension | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Recombinant human brain natriuretic peptide(Shijiazhuang wotai) | Phase 1 Clinical | Shijiazhuang wotai Biotechnology Co Ltd | Heart Failure; Acutely decompensated congestive heart failure | Details | |
PL-3994 | PL-3994 | Phase 2 Clinical | Palatin Technologies Inc | Heart Failure; Hypertension; Asthma | Details |
Recombinant human brain natriuretic peptide (Shanghai Jiao Tong University) | Phase 3 Clinical | Shanghai Jiaotong University | Heart Defects, Congenital; Tetralogy of Fallot | Details | |
Recombinant human brain natriuretic peptide (Suzhou Landing Bioteh) | Phase 1 Clinical | Suzhou RxD Biopharmaceutical Co Ltd | Heart Failure | Details | |
Nesiritide | hBNP; JNS-004; SC-70400; BNP-32 (human) | Phase 2 Clinical | Johnson & Johnson | Myocardial Ischemia; Hyperemia; Heart Failure; Renal Insufficiency; Acutely decompensated congestive heart failure; Sleep Disorders, Circadian Rhythm; Hypertension; Dyspnea; Coronary Disease; Cardiomyopathies; Cardiovascular Diseases; Hyperinsulinism; Obesity; Heart Failure, Systolic; Diabetes Mellitus | Details |
GNP | Phase 1 Clinical | Guangzhou Leien Kangya Biomedical Technology Co Ltd | Acutely decompensated congestive heart failure | Details | |
REGN-5381 | REGN-5381 | Phase 2 Clinical | Regeneron Pharmaceuticals Inc | Heart Failure | Details |
This web search service is supported by Google Inc.